Related Experiment Videos
Changes in chromatin structure associated with Alzheimer's disease
Journal of Neurochemistry
|November 1, 1981
Summary
Alzheimer disease brain chromatin is less accessible to micrococcal nuclease. This suggests altered chromosomal proteins in Alzheimer
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Alzheimer disease is a neurodegenerative disorder characterized by progressive cognitive decline.
- Chromatin structure plays a crucial role in regulating gene expression in the brain.
Purpose of the Study:
- To investigate chromatin accessibility in Alzheimer disease (AD) brains.
- To identify potential alterations in chromosomal proteins associated with AD.
Main Methods:
- Micrococcal nuclease digestion was used to assess chromatin accessibility in brain samples.
- Chromatin from AD patients was compared to control and non-Alzheimer dementia groups.
- Proteins associated with dinucleosomes were analyzed using SDS-PAGE.
Main Results:
- Alzheimer disease chromatin exhibited reduced accessibility to micrococcal nuclease compared to controls.
- This reduced accessibility was observed in both neuronal and glial chromatin.
- Elevated levels of specific perchloric acid-soluble proteins were found in Alzheimer dinucleosomes.
Conclusions:
- Chromatin structure is altered in Alzheimer disease brains.
- Specific chromosomal proteins, particularly in the histone H1 region, may be associated with AD pathogenesis.
- These findings represent the first evidence of altered chromosomal proteins linked to brain disease.